Hiroyuki Takeda

1.9k total citations
60 papers, 1.5k citations indexed

About

Hiroyuki Takeda is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hiroyuki Takeda has authored 60 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 19 papers in Oncology and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hiroyuki Takeda's work include Pancreatic and Hepatic Oncology Research (6 papers), Histone Deacetylase Inhibitors Research (6 papers) and Cancer Genomics and Diagnostics (6 papers). Hiroyuki Takeda is often cited by papers focused on Pancreatic and Hepatic Oncology Research (6 papers), Histone Deacetylase Inhibitors Research (6 papers) and Cancer Genomics and Diagnostics (6 papers). Hiroyuki Takeda collaborates with scholars based in Japan and United States. Hiroyuki Takeda's co-authors include Shuhei Suzuki, Shizuka Seino, Chifumi Kitanaka, Masashi Okada, Manabu Seino, Kenta Kuramoto, Keita Shibuya, Chawnshang Chang, Satoki Ueno and Yasushi Kitaoka and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and JNCI Journal of the National Cancer Institute.

In The Last Decade

Hiroyuki Takeda

52 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroyuki Takeda Japan 24 729 323 276 260 207 60 1.5k
Anita K. Harvey United States 22 526 0.7× 277 0.9× 154 0.6× 63 0.2× 103 0.5× 43 1.5k
Émilie Picard France 23 923 1.3× 442 1.4× 171 0.6× 725 2.8× 356 1.7× 58 2.1k
Tatsuya Tamura Japan 19 870 1.2× 745 2.3× 622 2.3× 24 0.1× 51 0.2× 33 2.0k
Xiang Da Dong United States 23 956 1.3× 303 0.9× 635 2.3× 204 0.8× 91 0.4× 69 1.7k
Yasushi Mochizuki Japan 18 597 0.8× 157 0.5× 153 0.6× 16 0.1× 43 0.2× 63 1.0k
Helge Löfberg Sweden 19 495 0.7× 117 0.4× 300 1.1× 51 0.2× 63 0.3× 32 1.6k
Raffaele Rossiello Italy 20 662 0.9× 206 0.6× 189 0.7× 11 0.0× 51 0.2× 52 1.4k
Rajashekhar Gangaraju United States 23 669 0.9× 84 0.3× 127 0.5× 260 1.0× 204 1.0× 64 1.4k
Chunsik Lee China 20 582 0.8× 144 0.4× 164 0.6× 152 0.6× 90 0.4× 46 1.1k
Suh-Hang Hank Juo Taiwan 27 786 1.1× 91 0.3× 474 1.7× 192 0.7× 175 0.8× 41 2.0k

Countries citing papers authored by Hiroyuki Takeda

Since Specialization
Citations

This map shows the geographic impact of Hiroyuki Takeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroyuki Takeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroyuki Takeda more than expected).

Fields of papers citing papers by Hiroyuki Takeda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroyuki Takeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroyuki Takeda. The network helps show where Hiroyuki Takeda may publish in the future.

Co-authorship network of co-authors of Hiroyuki Takeda

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroyuki Takeda. A scholar is included among the top collaborators of Hiroyuki Takeda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroyuki Takeda. Hiroyuki Takeda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Takeda, Hiroyuki, Shigeaki Nishina, Sho Suzuki, et al.. (2024). 486P Genomic profile differences between primary and recurrent tumors in curatively resected gastric cancer: The Liquid-GEAR study. Annals of Oncology. 35. S193–S194.
3.
Yamamoto, Hiroyuki, Hiroyuki Takeda, Yasuyuki Kojima, et al.. (2024). An approach for improvement of the accuracy of cancer gene panel testing. International Journal of Clinical Oncology. 29(5). 571–581. 2 indexed citations
4.
Yamamoto, Hiroyuki, Hiroyuki Arai, Ritsuko Oikawa, et al.. (2024). The Molecular Landscape of Gastric Cancers for Novel Targeted Therapies from Real-World Genomic Profiling. Targeted Oncology. 19(3). 459–471.
5.
Takeda, Hiroyuki, Kumiko Umemoto, Yu Sunakawa, et al.. (2024). Quality-of-life survey of pancreatic cancer patients: a comparison between general public and physicians. SHILAP Revista de lepidopterología. 4. 1275496–1275496.
6.
Mizukami, Takuro, Hiroyuki Takeda, Yoshiki Horie, et al.. (2021). Impact of Body Weight Loss on Survival in Patients with Advanced Gastric Cancer Receiving Second-Line Treatment. Nutrition and Cancer. 74(2). 539–545. 6 indexed citations
7.
Suzuki, Shuhei, et al.. (2021). Vimentin-positive and Alpha-fetoprotein-elevated Nuclear Protein of the Testis Midline Carcinoma: A Case Report and Review of the Literature. Internal Medicine. 60(22). 3645–3649. 4 indexed citations
8.
Takeda, Hiroyuki & Yu Sunakawa. (2021). Management of BRAF Gene Alterations in Metastatic Colorectal Cancer: From Current Therapeutic Strategies to Future Perspectives. Frontiers in Oncology. 11. 602194–602194. 7 indexed citations
9.
Takeda, Hiroyuki, Kumiko Umemoto, Hidefumi Mimura, et al.. (2020). Inferior mesenteric arteriovenous fistula during treatment with bevacizumab in colorectal cancer patient: A case report. World Journal of Gastrointestinal Oncology. 12(11). 1364–1371. 1 indexed citations
10.
Takeda, Hiroyuki, Rintaro Ohe, Tadahisa Fukui, et al.. (2019). Rapid Progression of Intracranial Dural Metastases in a Patient with Carcinoma of Unknown Primary Site. Case Reports in Oncology. 12(2). 666–670. 3 indexed citations
11.
Okada, Masashi, Hiroyuki Takeda, Kenta Kuramoto, et al.. (2017). Repositioning CEP-1347, a chemical agent originally developed for the treatment of Parkinson’s disease, as an anti-cancer stem cell drug. Oncotarget. 8(55). 94872–94882. 27 indexed citations
13.
Seino, Manabu, Masashi Okada, Hiroyuki Takeda, et al.. (2015). Time-staggered inhibition of JNK effectively sensitizes chemoresistant ovarian cancer cells to cisplatin and paclitaxel. Oncology Reports. 35(1). 593–601. 23 indexed citations
14.
Munemasa, Yasunari, Yasushi Kitaoka, Yasuhiro Hayashi, et al.. (2008). Effects of unoprostone on phosphorylated extracellular signal-regulated kinase expression in endothelin-1-induced retinal and optic nerve damage. Visual Neuroscience. 25(2). 197–208. 16 indexed citations
15.
Hayashi, Yasuhiko, Yasushi Kitaoka, Hiroyuki Takeda, et al.. (2007). Neuroprotective Effect of 17ß-Estradiol Against TNF- Induced Axonal Degeneration and p-ERK Expression. Investigative Ophthalmology & Visual Science. 48(13). 634–634. 1 indexed citations
16.
Hayashi, Joichiro, Hiroyuki Takeda, & Kitetsu Shin. (2006). A Case Report of Localized Aggressive Periodontitis Treated with Several Periodontal Regeneration Techniques. Nihon Shishubyo Gakkai Kaishi (Journal of the Japanese Society of Periodontology). 48(1). 40–49.
17.
Munemasa, Yasunari, Ritsuko Ohtani‐Kaneko, Yasushi Kitaoka, et al.. (2006). Pro‐apoptotic role of c‐Jun in NMDA‐induced neurotoxicity in the rat retina. Journal of Neuroscience Research. 83(5). 907–918. 25 indexed citations
18.
Takeda, Hiroyuki, et al.. (1998). Sphingomyelinase and ceramide inhibit formation of F‐actin ring in and bone resorption by rabbit mature osteoclasts. FEBS Letters. 422(2). 255–258. 21 indexed citations
19.
Takeda, Hiroyuki & Chawnshang Chang. (1991). Immunohistochemical and in-situ hybridization analysis of androgen receptor expression during the development of the mouse prostate gland. Journal of Endocrinology. 129(1). 83–NP. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026